Clinical trial
The Effect of Human Leukocyte Antigen Macthing on Guiding Tacrolimus Regimen
NCT03147157 is registered in ClinicalTrials.gov with The First Hospital of Jilin University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- The Effect of Human Leukocyte Antigen Macthing on Guiding Tacrolimus Regimen
- Lead sponsor
- The First Hospital of Jilin University
- Phase
- Not applicable
- Overall status
- Unknown status
- Start date
- May 31, 2017
- Completion date
- April 30, 2025
- Enrollment
- 120 (estimated)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
drug-related side effects and adverse reactions, graft rejection, graft versus host disease, liver transplantation